Ambiopharm

Description

• AmbioPharm, Inc. (APi) is a full-service peptide manufacturing company headquartered at our North Augusta, SC cGMP production site. Our second cGMP facility in Shanghai, China, performs process development & optimization, and manufactures building blocks, raw materials, and custom peptides at very large scale. Both our cGMP facilities are capable of handling any manufacturing scale required to produce bulk peptides to custom specifications using a wide range of skill sets in both solid and solution-phase chemistry. Our management team has over 100 years cumulative experience running pilot to commercial scale production. We also perform organic conjugations to small molecules, proteins, toxoids, antifungals, KLH, and PEG. In 2009, APi acquired small molecule cGMP manufacturing capabilities at our Shanghai campus enabling us to offer APIs based on peptide and small molecule chemistry. We are expert at a wide range of halogenated chemicals, with core competencies in fluorination of APIs and advanced intermediates.Management Team:Chris J. Bai, Ph.D, President and CEO with 19 years of experience in the peptide industry. Jim Hampton, B.S., MS, Executive Vice President of Business Development and cGMP Sales with 20 years of experience in the peptide industry.Ruoping Zhang, B.S., Vice President of Process Development and Manufacturing, with 12 years of experience in the peptide industry.Robert Geiger, Ph.D, MBA, Vice President of Quality with 13 years of experience in the peptide industry.
• 

  Headquarters:1024 Dittman Court , North Augusta, South Carolina, United States

  More
• 

  Phone Number: +1 803-442-7590

• 

  Website: https://www.ambiopharm.com

• 

  Employees:152

• 

  Revenue:$100 - 250M

• 

  Legal Name:Ambiopharm

• Ambiopharm's Social Media

  
• Is this data correct?

• |  NAICS Code: 325412  |

  Show More